James B. Tananbaum

Insider Reports History

Location
San Francisco, CA
Signature
/s/ James B. Tananbaum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James B. Tananbaum:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gemini Therapeutics, Inc. /DE Director, 10%+ Owner Common Stock 411,500 $27,837,975 $67.65 04 Oct 2021 Indirect
ALUMIS INC. Director, 10%+ Owner Common Stock 2,614,215 $19,292,906 $7.38 21 Nov 2025 Indirect
Quantum-Si Inc Director Class A Common Stock 4,463,619 $7,900,606 $1.77 10 Jun 2021 Foresite Capital Fund IV, L.P.
Quantum-Si Inc Director Class A Common Stock 2,342,061 $4,145,448 $1.77 10 Jun 2021 Foresite Capital Fund V, L.P.
Quantum-Si Inc Director Class A Common Stock 1,598,125 $2,828,681 $1.77 10 Jun 2021 By Foresite Capital Opportunity Fund V, L.P.
Quantum-Si Inc Director Class A Common Stock 20,512 $36,306 $1.77 11 Jun 2021 Direct
PARDES BIOSCIENCES, INC. President and CEO, Director, 10%+ Owner Common Stock 1,000 $1,500 $1.50 31 Aug 2023 Indirect
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 0 $0 $2.59 03 Apr 2024 By Fund
Gemini Therapeutics, Inc. /DE Director, 10%+ Owner Stock Option (Right to Buy) 17,245 04 Oct 2021 Direct
Kinnate Biopharma Inc. Director, 10%+ Owner Stock Option (right to buy) 0 03 Apr 2024 Direct
PARDES BIOSCIENCES, INC. President and CEO, Director, 10%+ Owner Stock Option (Right to Buy) 0 31 Aug 2023 Direct

Insider Reports Filed by James B. Tananbaum

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALMS ALUMIS INC. 21 Nov 2025 1 +$532,925 4 Director, 10%+ Owner 25 Nov 2025, 16:02
ALMS ALUMIS INC. 17 Nov 2025 4 +$3,094,725 4 Director, 10%+ Owner 19 Nov 2025, 20:51
ALMS ALUMIS INC. 02 May 2025 2 +$202,300 4 Director, 10%+ Owner 06 May 2025, 21:48
ALMS ALUMIS INC. 01 Jul 2024 32 +$40,000,000 4 Director, 10%+ Owner 03 Jul 2024, 21:30
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 Director, 10%+ Owner 27 Jun 2024, 21:31
KNTE Kinnate Biopharma Inc. 03 Apr 2024 5 $0 4 Director, 10%+ Owner 05 Apr 2024, 16:55
PRDS PARDES BIOSCIENCES, INC. 31 Aug 2023 5 $0 4 President and CEO, Director, 10%+ Owner 31 Aug 2023, 17:22
PRDS PARDES BIOSCIENCES, INC. 01 Jun 2023 1 $0 4 Director, 10%+ Owner 02 Jun 2023, 16:14
KNTE Kinnate Biopharma Inc. 08 May 2023 2 +$4,984,000 4 Director, 10%+ Owner 10 May 2023, 17:49
KNTE Kinnate Biopharma Inc. 17 Feb 2023 1 $0 4 Director, 10%+ Owner 22 Feb 2023, 13:50
KNTE Kinnate Biopharma Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 17:00
PRDS PARDES BIOSCIENCES, INC. 08 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 16:33
PRDS PARDES BIOSCIENCES, INC. 23 Dec 2021 1 $0 4/A Director, 10%+ Owner 10 Jun 2022, 16:17
PRDS PARDES BIOSCIENCES, INC. 23 Dec 2021 2 $0 4/A Director, 10%+ Owner 30 Dec 2021, 15:30
PRDS PARDES BIOSCIENCES, INC. 22 Dec 2021 1 +$3,250,000 4 Director, 10%+ Owner 23 Dec 2021, 15:52
IRON Gemini Therapeutics, Inc. /DE 04 Oct 2021 1 $0 4 Director, 10%+ Owner 06 Oct 2021, 16:15
QSI Quantum-Si Inc 10 Jun 2021 7 +$25,000,696 4 Director 14 Jun 2021, 18:55
QSI Quantum-Si Inc 10 Jun 2021 0 $0 3 Director 14 Jun 2021, 18:38